The evolution of two transmissible cancers in Tasmanian devils
M. R. Stammnitz, K. Gori, Y. M. Kwon, E. Harry, F. J. Martin, K. Billis, Y. Cheng, A. Baez-Ortega, W. Chow, S. Comte, H. Eggertsson, S. Fox, R. Hamede, M. E. Jones, B. Lazenby, S. Peck, R. Pye, M. A. Quail, K. Swift, J. Wang, J. Wood, K. Howe, M. R. Stratton, Z. Ning, E. P. Murchison
Abstract
Tasmanian devils have spawned two transmissible cancer lineages, named devil facial tumour 1 (DFT1) and devil facial tumour 2 (DFT2). We investigated the genetic diversity and evolution of these clones by analysing 78 DFT1 and 41 DFT2 genomes relative to a newly assembled chromosome-level reference. Time-resolved phylogenetic trees reveal that DFT1 first emerged in 1986 (1982-1989), and DFT2 in 2011 (2009-2012). Subclone analysis documents transmission of heterogeneous cell populations. DFT2 has faster mutation rates than DFT1 across all variant classes, including substitutions, indels, rearrangements, transposable element insertions and copy number alterations, and we identify a hypermutated DFT1 lineage with defective DNA mismatch repair. Several loci show plausible evidence of positive selection in DFT1 or DFT2, including loss of chromosome Y and inactivation of MGA, but none are common to both cancers. This study illuminates the parallel long-term evolution of two transmissible cancers inhabiting a common niche in Tasmanian devils.
02 /Specification & Classification
Click any tag to browse matching papers- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Contemporary and historical selection in Tasmanian devils (Sarcophilus harrisii) support novel, polygenic response to transmissible cancer
A. R. Stahlke, B. Epstein, … P. A. Hohenlohe·bioRxiv·Aug 7, 2020
- Tasman-PCR: A genetic diagnostic assay for Tasmanian devil facial tumour diseases
Young Mi Kwon, Maximilian R. Stammnitz, … Elizabeth P. Murchison·Royal Society Open SciencePeer-reviewed·Oct 1, 2018
- Response to "No evidence that transmissible cancer has shifted from emergence to endemism in Tasmanian devils"
Andrew T. Storfer, Mark J. Margres, … Paul A. Hohenlohe·bioRxiv·Jul 14, 2025
- Passage of transmissible cancers in the Tasmanian devil is due to a dominant, shared peptide motif and a limited repertoire of MHC-I allotypes
A. Gastaldello, S. H. Ramarathinam, … H. V. Siddle·bioRxiv·Jul 3, 2020
- Effects of a transmissible cancer on life-history traits in Tasmanian devils
Kasha Strickland, Menna E. Jones, … Loeske E. B. Kruuk·Proceedings of the Royal Society B Biological SciencesPeer-reviewed·May 1, 2025
- Automated analysis of PD1 and PDL1 in lymph nodes and the microenvironment of transmissible tumors in Tasmanian devils
G. G. Russell, C. Palmieri, … A. S. Flies·bioRxiv·Oct 31, 2022